Global Androgen Deprivation Therapy (ADT) Sales Market Report Forecast 2017-2022

July 2017 | 133 pages | ID: G09F8336EA4EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

Product Segment Analysis:

• Type 1
• Type 2
• Type 3

Application Segment Analysis:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 ANDROGEN DEPRIVATION THERAPY (ADT) MARKET OVERVIEW

1.1 Product Overview and Scope of Androgen Deprivation Therapy (ADT)
1.2 Classification of Androgen Deprivation Therapy (ADT)
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Androgen Deprivation Therapy (ADT)
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Androgen Deprivation Therapy (ADT) Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Androgen Deprivation Therapy (ADT) (2012-2022)
  1.5.1 Global Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2012-2022)
  1.5.2 Global Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON ANDROGEN DEPRIVATION THERAPY (ADT) INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 ANDROGEN DEPRIVATION THERAPY (ADT) MANUFACTURING COST ANALYSIS

3.1 Androgen Deprivation Therapy (ADT) Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Androgen Deprivation Therapy (ADT) Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Androgen Deprivation Therapy (ADT) Market Competition by Manufacturers
  5.1.1 Global Androgen Deprivation Therapy (ADT) Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Androgen Deprivation Therapy (ADT) Revenue and Share by Manufacturers (2012-2017)
5.2 Global Androgen Deprivation Therapy (ADT) (Volume and Value) by Type
  5.5.1 Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Type (2012-2017)
  5.5.2 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2012-2017)
5.3 Global Androgen Deprivation Therapy (ADT) (Volume and Value) by Regions
  5.3.1 Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Regions (2012-2017)
5.4 Global Androgen Deprivation Therapy (ADT) (Volume) by Application

6 UNITED STATES ANDROGEN DEPRIVATION THERAPY (ADT) (VOLUME, VALUE AND SALES PRICE)

6.1 United States Androgen Deprivation Therapy (ADT) Sales and Value (2012-2017)
  6.1.1 United States Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2012-2017)
  6.1.2 United States Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2017)
  6.1.3 United States Androgen Deprivation Therapy (ADT) Sales Price Trend (2012-2017)
6.2 United States Androgen Deprivation Therapy (ADT) Sales and Market Share by Manufacturers
6.3 United States Androgen Deprivation Therapy (ADT) Sales and Market Share by Type
6.4 United States Androgen Deprivation Therapy (ADT) Sales and Market Share by Application

7 CHINA ANDROGEN DEPRIVATION THERAPY (ADT) (VOLUME, VALUE AND SALES PRICE)

7.1 China Androgen Deprivation Therapy (ADT) Sales and Value (2012-2017)
  7.1.1 China Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2012-2017)
  7.1.2 China Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2017)
  7.1.3 China Androgen Deprivation Therapy (ADT) Sales Price Trend (2012-2017)
7.2 China Androgen Deprivation Therapy (ADT) Sales and Market Share by Manufacturers
7.3 China Androgen Deprivation Therapy (ADT) Sales and Market Share by Type
7.4 China Androgen Deprivation Therapy (ADT) Sales and Market Share by Application

8 EUROPE ANDROGEN DEPRIVATION THERAPY (ADT) (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Androgen Deprivation Therapy (ADT) Sales and Value (2012-2017)
  8.1.1 Europe Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2012-2017)
  8.1.2 Europe Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Androgen Deprivation Therapy (ADT) Sales Price Trend (2012-2017)
8.2 Europe Androgen Deprivation Therapy (ADT) Sales and Market Share by Manufacturers
8.3 Europe Androgen Deprivation Therapy (ADT) Sales and Market Share by Type
8.4 Europe Androgen Deprivation Therapy (ADT) Sales and Market Share by Application

9 JAPAN ANDROGEN DEPRIVATION THERAPY (ADT) (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Androgen Deprivation Therapy (ADT) Sales and Value (2012-2017)
  9.1.1 Japan Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2012-2017)
  9.1.2 Japan Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Androgen Deprivation Therapy (ADT) Sales Price Trend (2012-2017)
9.2 Japan Androgen Deprivation Therapy (ADT) Sales and Market Share by Manufacturers
9.3 Japan Androgen Deprivation Therapy (ADT) Sales and Market Share by Type
9.4 Japan Androgen Deprivation Therapy (ADT) Sales and Market Share by Application

10 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MANUFACTURERS ANALYSIS

10.1 Pfizer Inc. (USA)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Abbott Laboratories (USA)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Genentech Inc. (USA)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 GlaxoSmithKline Plc (UK)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Immunomedics, Inc. (USA)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Indevus Pharmaceuticals Inc. (USA)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Novartis AG (Switzerland)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 OSI Pharmaceuticals, Inc. (USA)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Paladin Labs Inc. (Canada)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

...

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL ANDROGEN DEPRIVATION THERAPY (ADT) MARKET FORECAST (2017-2022)

13.1 Global Androgen Deprivation Therapy (ADT) Sales, Revenue Forecast (2017-2022)
13.2 Global Androgen Deprivation Therapy (ADT) Sales Forecast by Regions (2017-2022)
13.3 Global Androgen Deprivation Therapy (ADT) Sales Forecast by Type (2017-2022)
13.4 Global Androgen Deprivation Therapy (ADT) Sales Forecast by Application (2017-2022)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

FIGURE PICTURE OF ANDROGEN DEPRIVATION THERAPY (ADT)

Table Classification of Androgen Deprivation Therapy (ADT)
Figure Global Sales Market Share of Androgen Deprivation Therapy (ADT) by Type in 2016
Table Applications of Androgen Deprivation Therapy (ADT)
Figure Global Sales Market Share of Androgen Deprivation Therapy (ADT) by Application in 2016
Figure United States Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2022)
Figure China Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2022)
Figure Europe Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2022)
Figure Japan Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2022)
Figure Global Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2012-2022)
Figure Global Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2022)
Table Global Androgen Deprivation Therapy (ADT) Sales of Key Manufacturers (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers (2012-2017)
Figure 2015 Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers
Figure 2016 Androgen Deprivation Therapy (ADT) Sales Share by Manufacturers
Table Global Androgen Deprivation Therapy (ADT) Revenue by Manufacturers (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers
Table 2016 Global Androgen Deprivation Therapy (ADT) Revenue Share by Manufacturers
Table Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Type (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Sales Share by Type (2012-2017)
Figure Sales Market Share of Androgen Deprivation Therapy (ADT) by Type (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Sales Growth Rate by Type (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Type (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Androgen Deprivation Therapy (ADT) by Type (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Revenue Growth Rate by Type (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Regions (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Sales Share by Regions (2012-2017)
Figure Sales Market Share of Androgen Deprivation Therapy (ADT) by Regions (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Sales Growth Rate by Regions (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Revenue and Market Share by Regions (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Androgen Deprivation Therapy (ADT) by Regions (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Revenue Growth Rate by Regions (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Sales and Market Share by Application (2012-2017)
Table Global Androgen Deprivation Therapy (ADT) Sales Share by Application (2012-2017)
Figure Sales Market Share of Androgen Deprivation Therapy (ADT) by Application (2012-2017)
Figure Global Androgen Deprivation Therapy (ADT) Sales Growth Rate by Application (2012-2017)
Figure United States Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2012-2017)
Figure United States Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2017)
Figure United States Androgen Deprivation Therapy (ADT) Sales Price Trend (2012-2017)
Table United States Androgen Deprivation Therapy (ADT) Sales by Manufacturers (2012-2017)
Table United States Androgen Deprivation Therapy (ADT) Market Share by Manufacturers (2012-2017)
Table United States Androgen Deprivation Therapy (ADT) Sales by Type (2012-2017)
Table United States Androgen Deprivation Therapy (ADT) Market Share by Type (2012-2017)
Table United States Androgen Deprivation Therapy (ADT) Sales by Application (2012-2017)
Table United States Androgen Deprivation Therapy (ADT) Market Share by Application (2012-2017)
Figure China Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2012-2017)
Figure China Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2017)
Figure China Androgen Deprivation Therapy (ADT) Sales Price Trend (2012-2017)
Table China Androgen Deprivation Therapy (ADT) Sales by Manufacturers (2012-2017)
Table China Androgen Deprivation Therapy (ADT) Market Share by Manufacturers (2012-2017)
Table China Androgen Deprivation Therapy (ADT) Sales by Type (2012-2017)
Table China Androgen Deprivation Therapy (ADT) Market Share by Type (2012-2017)
Table China Androgen Deprivation Therapy (ADT) Sales by Application (2012-2017)
Table China Androgen Deprivation Therapy (ADT) Market Share by Application (2012-2017)
Figure Europe Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2012-2017)
Figure Europe Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2017)
Figure Europe Androgen Deprivation Therapy (ADT) Sales Price Trend (2012-2017)
Table Europe Androgen Deprivation Therapy (ADT) Sales by Manufacturers (2012-2017)
Table Europe Androgen Deprivation Therapy (ADT) Market Share by Manufacturers (2012-2017)
Table Europe Androgen Deprivation Therapy (ADT) Sales by Type (2012-2017)
Table Europe Androgen Deprivation Therapy (ADT) Market Share by Type (2012-2017)
Table Europe Androgen Deprivation Therapy (ADT) Sales by Application (2012-2017)
Table Europe Androgen Deprivation Therapy (ADT) Market Share by Application (2012-2017)
Figure Japan Androgen Deprivation Therapy (ADT) Sales and Growth Rate (2012-2017)
Figure Japan Androgen Deprivation Therapy (ADT) Revenue and Growth Rate (2012-2017)
Figure Japan Androgen Deprivation Therapy (ADT) Sales Price Trend (2012-2017)
Table Japan Androgen Deprivation Therapy (ADT) Sales by Manufacturers (2012-2017)
Table Japan Androgen Deprivation Therapy (ADT) Market Share by Manufacturers (2012-2017)
Table Japan Androgen Deprivation Therapy (ADT) Sales by Type (2012-2017)
Table Japan Androgen Deprivation Therapy (ADT) Market Share by Type (2012-2017)
Table Japan Androgen Deprivation Therapy (ADT) Sales by Application (2012-2017)
Table Japan Androgen Deprivation Therapy (ADT) Market Share by Application (2012-2017)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc (UK) Androgen Deprivation Therapy (ADT) Global Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Immunomedics, Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Indevus Pharmaceuticals Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG (Switzerland) Androgen Deprivation Therapy (ADT) Global Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure OSI Pharmaceuticals, Inc. (USA) Androgen Deprivation Therapy (ADT) Global Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Paladin Labs Inc. (Canada) Androgen Deprivation Therapy (ADT) Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Androgen Deprivation Therapy (ADT)
Figure Manufacturing Process Analysis of Androgen Deprivation Therapy (ADT)
Figure Androgen Deprivation Therapy (ADT) Industrial Chain Analysis
Table Raw Materials Sources of Androgen Deprivation Therapy (ADT) Major Manufacturers in 2016
Table Major Buyers of Androgen Deprivation Therapy (ADT)
Table Distributors/Traders List
Figure Global Androgen Deprivation Therapy (ADT) Sales and Growth Rate Forecast (2017-2022)
Figure Global Androgen Deprivation Therapy (ADT) Revenue and Growth Rate Forecast (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Sales Forecast by Regions (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Sales Forecast by Type (2017-2022)
Table Global Androgen Deprivation Therapy (ADT) Sales Forecast by Application (2017-2022)